Banque Cantonale Vaudoise »

Denali Therapeutics shares owned by Banque Cantonale Vaudoise

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Banque Cantonale Vaudoise from 13F filings

Historical chart of Banque Cantonale Vaudoise investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Banque Cantonale Vaudoise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Banque Cantonale Vaudoise

Quarter filed Position value Share count Share price at filing
2026-06-30 $461k 18k 25.72

More positions owned by Banque Cantonale Vaudoise

Alcon Ord Shs (ALC)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Amrize SHS (AMRZ)
Caterpillar (CAT)
Cisco Systems (CSCO)
Alphabet Cap Stk Cl C (GOOG)
Abbvie (ABBV)
Coca-Cola Company (KO)
Astrazeneca Ord Add (AZN)
Eaton Corp SHS (ETN)
Bristol Myers Squibb (BMY)
Corning Incorporated (GLW)
Chubb (CB)
Cameco Corporation (CCJ)

View all positions for Banque Cantonale Vaudoise

Top funds holding Denali Therapeutics

BlackRock
Baillie Gifford & Co
Temasek Holdings
Vanguard Portfolio Management
Vanguard Capital Management
State Street Corporation
FMR
Goldman Sachs Group
Geode Capital Management
Holocene Advisors
Baker Bros. Advisors
Ubs Global Asset Management Americas
UBS Group
Alliancebernstein
Dimensional Fund Advisors

View all funds holding Denali Therapeutics